Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
82,216,167
-
Shares change
-
+1,651,799
-
Total reported value, excl. options
-
$1,909,846,418
-
Value change
-
+$45,174,636
-
Put/Call ratio
-
0.45%
-
Number of buys
-
79
-
Number of sells
-
100
-
Price
-
$23.23
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2023
As of 31 Mar 2023 MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) had 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 82,216,167 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, EARNEST PARTNERS LLC, DIMENSIONAL FUND ADVISORS LP, and Artisan Partners Limited Partnership.
This table shows 186 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.